Ellipsis Health’s technology uses AI and machine learning to identify, measure and monitor stress, anxiety and depression among patients using a short voice sample. Tiatros will use the technology to triage, care for and monitor patients between sessions in hopes of making care more accessible and manageable for patients, according to a Nov. 14 news release from Ellipsis.
“We are excited to be working with [Ellipsis Health] to create transformative opportunities to advance the use of vocal biomarkers in mental health and to support persistent patient assessments that enable Tiatros to adapt to individual patients’ needs and preferences,” Kimberlie Cerrone, Tiatros founder and CEO, said in the release.
At the Becker's Fall Behavioral Health Summit, taking place November 4–5 in Chicago, behavioral health leaders and executives will explore strategies for expanding access to care, integrating services, addressing workforce challenges and leveraging innovation to improve outcomes across the behavioral health continuum. Apply for complimentary registration now.